LENZ
LENZ Therapeutics Inc
3.70$
-1.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | – | – | 100.0% | |
| – | – | – | 55.6% | – | – | 3.7% | |
| – | – | – | 100.0% | – | – | 96.3% | |
| – | – | – | 140.8% | – | – | 97.8% | |
| – | – | – | 29.1% | – | – | 477.5% | |
| – | – | – | 169.9% | – | – | 573.8% | |
| – | – | – | -69.9% | – | – | -477.5% | |
| – | – | – | -69.8% | – | – | -427.6% | |
| – | – | – | 2.3% | – | – | 2.6% | |
| – | – | – | -72.1% | – | – | -430.3% | |
| – | – | – | -69.7% | – | – | -426.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.